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ABSTRACT PAGE
Thermoregulatory neurons in the preoptic area of the anterior 
hypothalamus (POA) form synaptic networks, which affect responses 
that regulate body temperature. In order to characterize these 
pathways of activation, projections to effector control areas, like the 
dorsomedial hypothalamus (DMH) or raphe pallidus (RPa), require 
labeling in live tissue slices. Traditional fluorescent dyes label axon 
terminals near an injection site, and unfortunately, also that of nearby 
fibers of passage. Here, we describe a novel methodology for 
retrograde labeling of neurons in vitro, while also allowing for further 
electrophysiological recording. To determine if POA neurons project to 
either the DMH or RPa, we have used nanometer-sized, gold 
nanoprobes, which provide for specific neuronal entry, via synapses in 
close proxim ity to the injection site. Upon neuronal entry, these 
nanoprobe complexes transport to the soma, where they are readily 
visualized and quantified. We found that conjugation of these gold 
nanoprobes with VGLUT-2 antibodies and polyethyleneimine (PEI) 
facilitate neuronal entry among glutamatergic neurons, with high 
levels of labeling efficacy with the POA. Probes with VGAT and PEI, on 
the other hand, which are designed to preferentially enter GABAergic 
neurons, show modest labeling of the POA. This novel method, 
adapted from emerging cancer therapy technologies, is highly specific 
for determining axon terminal projections within particular neuronal 
populations, while simultaneously maintaining neuronal viability for 
targeted live cell electrophysiological recording.
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CHAPTER Is
Thermoregulation and the Hypothalamus
THERMOREGULATION
Homeostasis involves the dynamic interaction between an 
organism's internal processes and its external environment to maintain 
physiological stability. One such homeostatic process is 
thermoregulation. Among animals, there are thermoconformers and 
thermoregulators. A thermoconformer's body temperature changes 
based on external temperature, whereas a thermoregulator maintains 
its body temperature within a particular range, in response to various 
external, environmental stimuli. Among thermoregulators, failure to 
achieve thermoregulatory balance may result in physiological damage, 
metabolic irregularities, or even death (Boulant, 2000).
In order to maximize heat loss in warm environments, mammals 
typically employ a number of adaptations. These include physiological 
strategies such as evaporative cooling (i.e. panting, perspiration), 
highly vascularized extremities, and compartmentalized fat storage to 
reduce insulation (e.g. camels). Other strategies involve behavioral 
adaptations such as daytime burrowing and increased nocturnal 
activity. Conversely, mammals utilize a variety of strategies to retain 
heat in cold environments. Physiologically, vascular countercurrent 
exchange systems mitigate heat escaping through the extremities, by
transferring heat from outgoing arterial to incoming venuous blood. 
Metabolic adaptation includes the ability to store metabolic energy in 
the form of fat. Through thermogenesis, energy can be released 
rapidly (e.g. shivering) or gradually (e.g. liver). Furthermore, 
evolutionary pressures also select for advantageous anatomical 
features, such as shortened extremities, or increased body size to 
more easily facilitate a steady core body temperature (Hammel and 
Pierce, 1968).
Humans are thermoregulators and have thus been able to adapt 
to a diverse set of climates. In cooler conditions, the human body 
engages in thermogenesis (e.g. liver processes and muscle 
contractions) to produce heat, and vasoconstriction to retain heat. In 
warmer environments, humans engage in vasodilation and sweating to 
transfer excess heat through evaporation. In addition to physiological 
mechanisms, humans also employ other social (e.g. huddling), cultural 
(e.g. clothing), and technological adaptations to produce or retain 
heat.
Thermometers provided the means to accurately measure 
temperature in animals. Because rates of heat loss and heat 
production vary in different parts of the body, local temperature
readings may differ considerably. Although circulating blood tends to 
standardize body temperature, the identification of body parts that 
closely match those of the internal organs have proven useful in 
ascertaining core temperature. These body parts include the rectum, 
uterus, bladder, mouth, ear, and groin (Hammel and Pierce, 1968).
Heat Loss
When environmental temperature is above core body 
temperature, humans lose heat through evaporation by secreting 
sweat. Furthermore, dermal hairs lie flat to prevent air retention 
between them, and thus complement convective heat loss. 
Vasodilation is another mechanism by which humans lose heat. 
Relaxation of smooth muscle in arteriole walls increases arterial blood 
flow. By redirecting blood to distal parts of the body, such as the skin, 
heat is lost through radiation and convection. In contrast to humans, 
only few other mammals lose heat primarily through sweating (e.g. 
horses). Rats, mice, cats, and dogs possess sweat glands exclusively 
on their foot pads. Instead, many mammals (e.g. dogs) pant to cool 
their bodies. Highly vascularized lungs, with a large surface area, 
facilitate heat exchange between the air and the ir bodies.
5Heat Retention/Production
In contrast to heat loss, humans apply the opposite mechanisms 
to retain heat whenever environmental temperature dips below core 
body temperature. Sweat pathways are deactivated. Vasoconstriction 
is achieved by constricting subdermal capillaries and thus, shunting 
blood away from the skin and the body's periphery. In extremely cold 
conditions, prolonged rerouting of blood away from the extremities 
causes numbness and cellular damage (e.g. frostbite). To augment 
heat retention, humans contract miniscule subdermal muscles (erector 
pili) to erect dermal hair follicles. These erect hairs form an insulating 
layer capable of trapping heat. Furthermore, humans and some 
animals produce heat in an exothermic process called thermogenesis. 
Effector signal from the hypothalamus reach peripheral muscles to 
cause shivering. Humans engage in short-term shivering, where heat 
is produced through high-intensity glucose metabolism in a relatively 
short period of time. Other animals, such as bears, are capable of 
long-term shivering, often for months, by gradually and steadily 
metabolizing fat stores.
Circadian Rhythm
Daily variations in body temperature have been observed in 
mammals, particularly humans and rats. The daily peak of body 
temperature rhythm in rats was found to consistently follow the daily 
peak of heat production rhythm and to precede the daily peak of heat 
loss rhythm. Furthermore, the daily rhythm of heat balance is 180 
degrees out of phase with the rhythm of body temperature. Animals 
with lesions in the dorsomedial nucleus of the hypothalamus (DMH) 
maintained a normal circadian variation, though body temperature 
remained 0.5°C lower. Rat studies have shown that the circadian 
rhythm may be inverted by restricting food access to daylight hours. 
When only permitted to eat during the latter half of the light period, 
these animals awaken and increase body temperature a few hours 
before food administration. Lesion studies have determined that the 
ability to alter rhythms in body temperature, as well as the wake-sleep 
cycle, feeding, activity, and corticosteroid rhythms, correlate with DMH 
activity (Refinetti, 2003).
Sleep
Mammals sleep to conserve energy, during which decreased body and 
brain temperatures are observed. Small mammals tend to sleep the 
most, since they also have higher energy demands for 
thermoregulation and locomotion, while possessing relatively lower 
energy reserves. Disruption of normal sleep cycles has been associated 
with thermoregulatory irregularities. For example, chronically sleep- 
deprived rats show increased preference for cooler ambient 
temperatures (~10°C), which suggests sleep has cooling function. 
Conversely, rats sleep deprived for two weeks show a significant 
decrease in body temperature despite a doubling in metabolic rate, 
suggesting sleep's role in heat retention. In humans, increased 
hypothalamic temperature induces sleep, and body heating prior to 
sleep increases subsequent slow wave sleep (Saper et al., 2005).
HYPOTHALAMUS
Found in all mammalian brains, the hypothalamus is located ventral to 
the thalamus, where it coordinates certain metabolic processes and 
various autonomic nervous system activities, as well as, synthesizes 
and secretes particular hormones. Stimulation and ablation studies
8have determined that the preoptic anterior part of the hypothalamus 
(POA) is crucial for thermoregulation (Hammel et al., 1963). 
Approximately 40% of POA neurons are temperature-sensitive, while 
the rest are insensitive. Local warming of POA neurons evoked heat 
loss responses, where as local cooling induced heat production. This 
observation led to the idea that the POA as an area responsible for 
thermoregulatory control, i.e. the body's "central thermostat"
(Boulant, 2000).
Hammers Model
In the 1960s, the six-neuron Hammers model, named after its 
developer, proposed that set-point temperature was determined by 
the integration of afferent signals with neuronal interactions within 
POA (Fig. 1). The model proposed that warm-sensitive neurons 
positively synapse on warm effector
neurons, whereas temperature-insensitive inhibit them. The 
temperature where excitation equals inhibition determines is the set- 
point. Above the set-point temperature, warm effector neurons receive 
more stimulation than inhibition, thus leading to heat loss behavior. 
Conversely, temperature-insensitive neurons positively synapse on 
cold effector neurons, whereas warm-sensitive inhibit them. Below the
set-point temperature, cold effector neurons receive more stimulation 
than inhibition, thus initiating heat retention/production behavior 
(Hammel et al., 1963).
Neuroanatomical Correlates
Observed heat loss behaviors include vasodilation, panting, and 
sweating, while heat production behaviors involve vasoconstriction, 
shivering, breakdown of brown adipose tissue, and huddling. Further 
studies have determined that heat loss and production are triggered 
by the actual ambient temperature, and not by the rate of change in 
temperature, since no burst of neuronal firing rates were detected 
during rapid temperature change. Hypothalamic temperature does not 
vary considerably (range: ± 1°C) even when ambient temperature is 
changed drastically. However, drops in hypothalamic temperature 
below this range often induce a coma and other neuroprotective 
mechanisms (Hammel et al., 1963).
10
Figure 1. Ham m ers Model. A modified six-neuron model explaining 
the hypothalamic determination of set-point temperature. Key: FR, 
firing rate; W, warm-sensitive neuron; I, temperature-insensitive 
neuron; w, heat loss effector neuron having synaptically derived-warm 
sensitivity; c, heat production effector neuron having synaptically- 
derived cold sensitivity; SP, dorsal horn spinal neuron; OC, optic 
chiasm; MB, mammillary body. Adapted with permission from Boulant, 












Changes in the activity of neurons in the POA have been correlated 
with initiation of thermoregulatory mechanisms. Nearby areas, such as 
the DMH, may include thermoeffector neuron. Electrical stimulation of 
the DMH induced an increase in heat production behavior. Retrograde 
labeling show dye beads transported to the lateral hypothalamus (LH), 
POA, ventromedial preoptic (VMPO), and paraventricular area (PVN). It  
is thought that the POA may have direct control of the DMH 
(Nakamura et al., 2005).
Neuronal Thermosensitivity
Various in vivo and in vitro electrophysiology studies have identified 
four types of thermoregulatory neurons: warm-sensitive, cold- 
sensitive, temperature-insensitive, and silent. Among these types, the 
vast m ajority of the POA neuronal population comprise of warm- 
sensitive (~30% ) and temperature-insensitive (~60% ) neurons. One 
main difference between these two types is that warm-sensitive 
neurons not only inherently respond to local thermal input, but also to 
hypothalamic, skin, and/or spinal temperature. Conversely, 
temperature-insensitive neurons do not exhibit temperature-related 
changes in activity (Boulant et al., 1997).
Thermal Classification
Historically, temperature sensitivity has been ascertained in one of two 
ways: either through the determination of a Qio thermal coefficient, or 
through calculation of the neuronal firing rate regression line slope.
The slope reflects the number of action potentials as a function of 
hypothalamic temperature (Boulant et al., 1997).
Using the latter criteria, temperature-sensitive neurons can be divided 
into two subgroups: warm- (35% POA) and cold-sensitive (5%). 
Warm-sensitive neurons fire at > 0.8 impulses/sec/°C, when the POA 
temperature is changed by ±  2-3°C (Boulant et al., 1997). Warm- 
sensitive neurons respond to both direct changes in hypothalamic 
temperature and peripheral thermal stimulation. They also have a 
distinct lateral/medial orientation in dendritic morphology, which is 
consistent with the ir roles as integrators of thermal information (Griffin 
et al., 2001). Cold-sensitive neurons, on the other hand, fire at < -0.6 
impulses/sec/°C when POA temperature is changed by ± 2-3°C. Unlike 
warm-sensitivity, cold-sensitivity is not an inherent property, and may 
be a result of synaptic input from nearby warm-sensitive and 
insensitive neurons (Boulant et al., 1997).
In contrast, temperature-insensitive neurons show little change in 
firing rate, when temperature deviates from the normal physiological 
condition (~37°C). Temperature-insensitive neurons fire at < 0.79 
impulses/sec/°C and > -0.6 impulses/sec/°C when the POA 
temperature is changed by ±  2-3°C. Essentially, this range is between 
the firing rates of warm- and cold-sensitive neurons (Boulant et al., 
1997). Unlike their warm-sensitive counterparts, temperature- 
insensitive neurons extend the ir dendrites in rostral/caudal directions, 
consistent with their roles as indicators of baseline of hypothalamic 
activity (Griffin et al., 2001).
The characterization of physical differences between temperature- 
sensitive and insensitive neurons is an active area of research. These 
differences in firing rates may be determined by various ionic 
conductances, such as tandem-pore K+ leak channels (TASK, TREK, 
and TRAAK), transient K+ A-current channels, hyperpolarization- 
activated cyclic nucleotide-gated channels (HCNs), and vanilloid 
transient receptor potential (TRP) channels. The proportion of these 
channels within the hypothalamus may explain the difference among 
warm-, cold-sensitive, and temperature-insensitive neurons 
(Wechselberger et al., 2006). I t  has been observed that increased 
temperature positively correlated with both firing rate
thermosensitivity and A-current inactivation, resulting in a higher 
probability of reaching firing threshold (Griffin et al., 1996).
MEDICAL IM PLICATIONS
Fever
Several studies estimate that the average core temperature for 
healthy adults is approximately 98.2 °F or 36.8 °C. When presented 
with an immunological challenge, the human body undergoes a 
cascade of factors that signal the brain. The resulting rise in body 
temperature of 1-4°C is defined as a fever. Metabolically, specific 
cytokines cause production of prostaglandin (PGE2) in the brain, which 
in turn affects neuronal activity in the ventramedial preoptic (VMPO; 
Blatteis and Sehic, 1998). Introduction of PGE2 to this region or 
stimulation of afferent pathways causes significant rise in body 
temperature (> 1° C). According to Hammers model, an increase in 
the firing rate of temperature-insensitive neurons and/or a decrease in 
the firing rate of warm-sensitive neurons result in a new, higher set- 
point. The presence of PGE2 causes warm-sensitive neurons to 
decrease their firing rate and temperature-insensitive neurons to be 
unaffected or increase their firing rate (Ranels and Griffin, 2003).
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Thermal Dvsreaulation
Because of the hypothalamus' importance in thermoregulation, 
injuries, tumors, genetic abnormalities, and its exposure to pyrogenic 
and other exogenous compounds may cause thermal dysregulation. 
Because the POA can be influenced by factors besides temperature, 
(e.g. glucose levels, testosterone, estrogen, osmotic balance, etc.), 
dysfunctions in maintenance of these factors may be comorbid with 
thermal dysregulation. Furthermore, metabolic and physiologic 
conditions, such as hormonal imbalance and poor blood circulation, 
may contribute to abnormal body temperature.
CONCLUSION
To summarize, thermoregulation is a dynamic, homeostatic interaction 
between an organism's internal processes and its thermal 
environment. To maintain physiological stability, many organisms 
employ processes such as heat loss, retention, and production. These 
thermoregulatory mechanisms influence other aspects of life, such as 
sleep and circadian rhythms. Among mammals, the hypothalamus 
(located deep within the brain) coordinates certain metabolic 
processes, regulates various autonomic nervous system activities, and
synthesizes/secretes particular hormones critical to thermoregulation. 
Through thermal dysregulation and protective mechanisms like fever, 
we are reminded of thermoregulation's importance in maintaining life.
Hypothesis:
Synaptic entry of novel nanoprobes within the DMH will result in 
somatic labeling in the POA, confirming connectivity. Probe 
conjugation, with either VGLUT-2 or VGAT antibodies, will facilitate 
preferential entry into either glutamatergic or GABAergic synapses.
SPECIFIC AIM :
Although recent evidence has suggested that POA neurons project to 
the DMH, direct demonstration of these connections and the distinct 
phenotypic populations responsible for the activation of 
thermoregulatory responses remains to be elucidated.
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CHAPTER I I :
In  Vitro Application of Gold Nanoprobes in Live Neurons for 
Phenotypical Classification, Connectivity Assessment, and 
Electrophysiological Recording
1. IN TR O D U C TIO N
Thermoregulatory neurons in the preoptic area of the anterior 
hypothalamus (POA) form synaptic networks, which affect responses 
that regulate body temperature around a set-point (Boulant, 1997; 
Hammel, 1965). Changes in this area's neuronal activity have been 
correlated with the initiation of thermoregulatory mechanisms (Griffin 
et al., 1996; Imbery et al., 2008; Saper and Breder, 1994). Recent 
studies also suggest that certain thermoregulatory phenomena, such 
as hyperthermia, can be elicited by activation of neurons in the 
dorsomedial hypothalamus (DMH) and the nucleus raphe pallidus 
(RPa), which receive direct input from neurons in the POA (Nakamura 
and Morrison, 2008; Nakamura et al., 2009). Therefore, in order to 
produce these distinct changes in thermoregulatory control, POA 
neurons may have direct axonal connections to the DMH or RPa. 
Although recent evidence has suggested that POA neurons project to 
these areas (Nakamura et al., 2009), direct demonstration of these 
connections and the distinct phenotypic populations responsible for the 
activation of thermoregulatory responses remains to be elucidated.
In order to determine the thermoregulatory role of POA neurons that 
project to the DMH or the RPa, their phenotypes and connectivity must 
be characterized. Past studies have attempted to phenotype these 
neurons through their synaptic projections. For example, certain 
techniques, such as glutamate decarboxylase staining, resulted in 
localization of not only the synapses of interest, but also nearby axonal 
fibers (Schaffer and Griffin, 2006). While the m ajority of POA neurons 
are thought to be inhibitory (Nakamura and Morrison, 2008;
Nakamura et al., 2009) and therefore GABAergic, the literature 
describes the glutamatergic system in more detail due to its 
abundance in the mammalian brain (Meldrum, 2000). This made the 
glutamatergic system more accessible for initial investigation. Once 
proof of principle was established, investigation of the GABAergic 
system subsequently followed.
Recent developments, in the field of bionanotechnology have yielded 
new approaches to supplement molecular studies at the subcellular 
level (Bergen et al., 2008; Grimm et al., 2004; Kukowska-Latallo et 
al., 2005; Merrifield et al., 2005). For example, metallic nanoparticles, 
through their biocompatibility and low toxicity, are gradually 
expanding drug delivery and cancer treatm ent options (Kukowska- 
Latallo et al., 2005; Sperling et al., 2008; Vasey et al., 1999). The
23
potential uses for nanoparticles, however, are not confined to these 
applications. In addition to therapeutic applications as vehicles, 
nanoparticles may expand bioimaging techniques as contrast agents, 
by functionally assessing and localizing specific molecular signatures or 
physiological systems (Portney and Ozkan, 2006; Shamsaie et al., 
2007; Thurn, 2007). Furthermore, because of the nanoparticles' 
metallic properties, the photoelectric effect neutralizes photobleaching 
concerns associated with conventional fluorescent dyes (Thurn, 2007).
Cellular metallic nanoparticle studies have recently come into 
existence, and literature involving neuronal applications are still 
evolving (Olivier, 2005). Here, we report an adaptation of this 
technology as a potential tagging system for neuronal pathway 
identification in vitro. Whereas previous studies involved gold 
nanoparticle vehicles delivering genetic or drug payloads to the 
nucleus of a cell (Olivier, 2005), we have adapted the original intent of 
these nanoparticles, whereby the payload (subsequently referred to as 
'conjugates') facilitate delivery of the vehicle (i.e. gold nanoparticle) to 
the neuronal soma. This has allowed us to characterize both 
glutamatergic and GABAergic neurons in a tissue slice preparation, 
which synapse in the DMH and originate from within the POA. Since 
the nanoparticles used are non-lipid soluble, and are specifically
conjugated to enter and escape the synaptic vesicular machinery, 
these nanoparticles allow us to probe for a neuron's somatic origin, via 
the synapse, by retrograde diffusion or facilitated transport.
Since thin neuronal tissue slices remain viable in vitro for up to 12 
hours under proper conditions, an appropriate retrograde labeling 
technique must work within this time period to allow for the targeted 
electrophysiological recording of these neurons in the POA. Other high- 
contrast, "gold standard" methods, such as Fluorogold (Llewellyn- 
Smith et al., 1990; Moore et al., 1995; Tong et al., 1999), cholera 
toxin B-gold, and immunogold silver staining exist. However, only our 
adapted gold nanoprobe (AuNP) technique simultaneously offers the 
appropriate time course, specificity, and low biotoxicity (Allen et al., 
1988; Chan et al., 1990; Cowan et al., 1994; Gillitzer et al., 1990; 
Naumann et al., 2000) required to leave neurons of interest suitably 
intact for live-cell recording. Finally, techniques lacking actual metallic 
components, like Fluorogold, exhibit lim itations found in fluorescent 
dyes, such as potential labeling of nearby fibers of passage (Chen and 
Aston-Jones, 1995; Dado et al., 1990) and photobleaching.
2. EXPERIMENTAL PROCEDURES
2.1 Hypothalamic Tissue from Rat Brain
Extraction procedures of hypothalamic tissue have been previously 
described in detail (Griffin et al., 1996; Griffin et al., 2001; Imbery et 
al., 2008; Olivier, 2005). Briefly, brain tissue sections containing the 
DMH and POA were prepared from male Sprague-Dawley rats (Harlan; 
100-150 g), that were housed under standard conditions and provided 
food and water ad lib. Before each session, a rat was anesthetized 
using isoflurane and promptly decapitated, following procedures 
approved by the Animal Care and Use Committee of the College of 
William and Mary. After dissection of the brain, a tissue block 
containing the hypothalamus was mounted on a vibratome and bathed 
in artificial cerebral spinal fluid (aCSF). Sagittal plane, 400 pm-thick 
tissue sections were produced and then placed in a submersion 
recording chamber.
2.2 Tissue Perfusion and Probe Injection
Tissue sections were continually perfused with normal aCSF, which 
consisted of (in mM): 124 NaCI, 26 NaHC0 3 / 10 glucose, 5 KCI, 2.4
CaCh, 1.3 MgS04/ and 1.24 KH2 PO4 . After gentle aeration (95% 02,
5% CO2 ), the aCSF (300 mOsM; pH 7.5) was allowed to gravity flow at 
1-2 m l/m in into the recording chamber (volume = 2 ml).
Approximately 1-5 pL of probe solution (AuNPs in bovine serum 
albumin suspension) were backfilled into glass microelectrodes pulled 
to a tip diameter of ~ 2-5 pm. The solution was pressure-injected into 
the tissue area of interest, using a nitrogen puffer system (Fig. 2). 
Successful injection sites aimed at the DMH, regardless of probe type, 
were designated as 'ta rget' tissue (n = 57), while non-DMH were 
'contro l' (n = 7). Tissue classified as non-DMH included injection sites 
in the anterior hypothalamic area (AHA) or the ventromedial 
hypothalamus (VMH). Probes were allowed to diffuse through the 
tissue for an average of 5.9 ± 0.1 h at a mean temperature of 35.5 ± 
0.18°C. A thermocouple was placed adjacent to the tissue slices to 
constantly monitor the temperature.
Upon tissue placement into the chamber, a small concentration of gold 
nanoprobes was pressure-injected into the DMH (Fig. 3). These AuNPs 
are spherical, colloidal nanoparticles composed of a dielectric silica 
core and an ultra-thin metallic (gold) coating, providing them with a 
strong reflectivity (peak wavelength: glutamatergic = 524 nm,
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GABAergic = 510 nm), and an extremely low biotoxicity. For our 
purposes, the glutamatergic AuNPs were conjugated with a polyclonal 
antibody for the rat vesicular glutamate transporter type-2 (VGLUT-2; 
Millipore) and polyethyleneimine (PEI; Nanopartz, Inc.).
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Figure 2. A natom ical and d istance o rien ta tio n  in in jected  tissue.
Tissue-level image (4x) o f in jection site in the DMH, labeled soma in 
the AHA/POA, and o ther anatom ical landmarks.
DMH: dorsomedial hypothalam us
Fx: fo rn ix
AC: anterio r commissure
AHA: anterio r hypothalam us, which contains the POA
A, B: arrows pointing to labeled soma
200 urn
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Figure 3. Schem atic  D iagram  o f Probe A or Z's M echanism .
Probe in jection in the DMH allows vesicular uptake at the axon 
te rm ina l, (a) Probe conjugates, such as VGLUT-2 or VGAT antibodies 
(curvy line) and PEI molecules (Y-shape), are surface-conjugated on 
gold nanoshells (circle), (b) These conjugates facilita te  m embrane 
protein a ttachm ent during vesicular form ation and, later, (c) 
endosomal escape from  the vesicular lumen into the cytosol. 
In trace llu la r diffusion and possible retrograde axonal transport 
m achinery facilita tion  result in nanoaggregate deposition in the 
neuronal soma.
This fully-conjugated nanoprobe complex, consisting of both V-GLUT-2 
antibodies and PEI polymers attached onto a gold nanoshell (diameter 
= 5 nm), was designated as Probe A. GABAergic probe complexes 
were similarly constructed, only that the VGLUT-2 antibodies were 
replaced with polyclonal antibodies for the rat vesicular GABA 
transporter (VGAT; Millipore; peak wavelength = 510 nm). The VGAT 
and PEI double-conjugated probe was designated Probe Z. From this 
point onwards, administration methodology and experimental 
conditions for the VGAT probes were similar to the VGLUT-2 probes.
After injection into the tissue slice, specific antibody binding of Probe A 
to nearby VGLUT-2s (which are exposed to the terminal surface during 
vesicle formation) facilitates AuNP uptake exclusively into synaptic 
vesicles at axon terminals (Jung et al., 2006). Once inside a newly- 
formed vesicle, "endosomal escape" occurs when the attached, 
cationic PEI conjugates sequester surrounding protons. To maintain 
chemiosmotic balance, vesicular ATPases continue to pump protons 
into the vesicular space. To maintain electrochemical balance, chloride 
ions follow into the vesicle, through their own channels. Increasing 
concentrations of both ions attract water molecules into the vesicular 
lumen, initiating a progressive "proton sponge effect" (Bergen et al., 
2008; Guerra-Crespo et al., 2003; Suk et al., 2007; Wu et al., 2004).
Upon hydrosaturation, the vesicles lyse and a significant number of 
AuNPs diffuse into the cytosol. Over the next several hours, while the 
tissue slice equifibrates to the chamber environment, some AuNPs will 
retrogradely transport from the synaptic terminal region to the 
neuronal soma (Bergen et al., 2008; Suk et al., 2007).
2.3 Histology
Upon removal from the recording chamber, the tissue sections were 
allowed to soak in 30% paraformaldehyde/sucrose solution at 12°C for 
a minimum of 3 h. Tissue was frozen and sliced into 50 pm thick 
sections using a microtome (Leica SM-2000R). After suspension in 
phosphate-buffered saline, the tissue sections were mounted on slides 
and were given 12 h to dry at room temperature before beginning the 
staining process. Slides were first placed in a 50/50 chloroform/alcohol 
solution for 3 h at room temperature. Afterwards, they were carried 
through a series of rehydration steps, for five minutes each in 300 ml_ 
of, successively, 95.5% reagent alcohol, 70% reagent alcohol, and 
distilled water, followed by a 5 min submersion in phosphate buffer 
monobasic solution and 4 min in giemsa stain. Excess stain was then 
removed via 2 min agitation in 95.5% reagent alcohol before the slides
were placed in 300 mL of xylene (Sigma, 98.5+% ) for 12 h. Slides 
were coverslipped and allowed 12 h to set before microscopy.
2.4 Probe Visualization and Quantification
The location and confirmation of each injection site were noted on a 
section diagram adapted from a rat brain atlas (Pellegrino et al.,
1979). Quantification of the probes involved tallies of labeled neurons 
and their location. Labeled neurons were readily identified by the 
presence of AuNPs in their giemsa-stained somas, which can be 
visualized under normal bright field illumination, and then confirmed 
through their reflective properties under dark field illumination. To 
reduce bias, undergraduate counters were blinded to the tissue 
sample's probe treatment. Microscopy images were obtained using an 
Olympus CCD camera (DP11) at 4x, lOx, and 40x magnification. Fuil- 
image brightness and contrast were non-destructively adjusted using 
Adobe Photoshop.
2.5 Control Probe Configurations
To determine the differential contribution of the complex's 
components, isolation of individual component effects was required. To 
accomplish this, progressively simpler, control probes were designed
by removing individual modifications. After testing the performance of 
the complete probe (Probe A; AuNP + VGLUT2 antibody + PEI), we 
studied the properties of Probe B (AuNP + VGLUT2 antibody only), 
Probe C (AuNP + PEI only), and finally Probe D (AuNP shell only, 
diameter = 5 nm). All probes were synthesized by Nanopartz, Inc.
2.6 Colchicine Treatment
To determine whether passive diffusion or facilitated transport through 
the axonal machinery is the primary mode by which the probes reach 
the soma, 100 nM of the microtubule formation inhibitor colchicine 
(Sigma-Aldrich; dissolved in distilled water) was co-administered with 
Probe A (n = 8). Both Probe A and colchicine solution were backfilled 
onto the same electrode prior to pressure injection.
2.7 Statistical Analysis
Mann-Whitney U-tests (nonparametric data) or Student's T-tests 
(parametric data) were conducted when comparing two treatment 
groups, whereas a Kruskal-Wallis test was utilized for three or more. 
Chi-square tests were used to compare between probe efficacy results. 
To determine which factors influence the quantity of labeled neurons
within the POA, a principal components analysis (PCA) was used to 
develop a multiple regression model. Robust regression confidence 
intervals and standard errors were generated using a replacement- 
and-resampling bootstrap method (Efron, 1977; Efron, 1994). These 
estimates were bias-corrected and validated using a separate jackknife 
procedure (Efron, 1977). Unless otherwise noted, P-values < 0.05 
were stated as statistically significant. Statistical analyses were 
performed using Stata 10 (StataCorp. LP).
3. RESULTS
Trials assessing the efficacy of Probe A yielded results dependent on 
initial probe injection location. Significant differences in somatic 
labeling were observed between tissues injected in the DMH as 
compared to non-DMH tissues (Fig. 4), whereby probe injection into 
the DMH resulted in significantly higher POA somatic labeling. DMH- 
injected samples also displayed a relatively higher variance in POA 
labeling compared to non-DMH, with at least one sample exhibiting 
over 60 labeled soma. Discrete reflecting units within clearly-marked 
somas were observed (Fig. 5 a,b,c). Reflectance observed does not 
represent individual nanoprobe complexes, since individually, these 
particles have insufficient surface area to reflect the necessary amount 
of light perceivable to the human eye. Instead, what we are likely 
seeing are collections of several probes that can be best described as 
nanoaggregates (Kneipp et al., 2006). An adjusted density map was 
constructed to visualize Probe A's spatial distribution in DMH-injected 
tissue (n = 20). In tissue slices with confirmed injection sites in the 
DMH, the majority of labeled cells were located near the POA. Not 
surprisingly, the highest densities (excluding areas immediately 
surrounding the injection site) were observed in the rostral sections of
Figure 4. Efficacy of Probe A of DMH vs. non-DMH Tissue. The
number of labeled POA neurons is significantly higher, if the injection 
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Figure 5 a, b, and c. Microscope images of labeled neurons.
Images (40x) in visible light (a), dark field (b), and superimposed 
composite (c) show distinct probe nanoaggregates within giemsa- 
stained POA soma. Arrows indicate labeled soma.
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the POA -- the area closest to the DMH (Fig. 6). In contrast, control 
tissue with injection sites to the mammillary peduncle or AHA, showed 
significantly lower POA somatic labeling. Outside the POA, probes were 
relatively scattered. Higher probe accumulations reported in soma 
closer to the injection site (i.e. labeled, non-POA neurons) may reflect 
shorter traveling times due to smaller distances. Longer perfusion 
times may result in increased labeling within the POA proper, though 
this speculation may require further testing. Another possibility is that 
Probe A is term inally labeling somas in the area rostral to the POA. If  
that is the case, this may provide evidence that this area may also 
provide effector signals to the DMH. Due to time lim itations, we were 
not able to investigate this possibility further. Future experiments may 
be warranted to provide answers.
A linear, multiple regression model was developed to determine the 
incremental effect of probe type, location of injection site, diffusion 
time, and perfusion temperature respectively, on the number of POA 
neurons labeled. All explanatory variables were assessed for 
collinearity, and ail showed sufficient independence. The regression 
model significantly explained approximately 50% of the POA labeling 
variation.
Bootstrapped linear regression models (n = 45, iterations = 10,000) 
indicate that, overall POA labeling was significantly affected by probe 
configuration and injection site (Table 1). Injection in the DMH yielded, 
on average, significantly more POA labeling, after controlling for probe 
type and other factors. Although diffusion time differences did not 
show significance at the a < 0.05 level (most tissue slices were 
perfused for approximately 6 hours with minimal variation), future 
investigation and manipulation of this variable may be informative.
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Figure 6. Probe A spatial distribution. Normalized spatial 
distribution of Probe A in DMH-injected tissue (n = 20) show higher 
labeling density in the anterior POA and areas immediately rostral to 
the POA. Grid: The origin represents the DMH injection site. Higher 
axis numbers indicate a more dorsal direction, while latter axis letters 
indicate a more caudal direction. Legend: Number of labeled neurons 
observed averaged over 20 slices.
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Table 1. Labeling Efficacy by Probe Configuration. Estimated 
incremental contributions of each conjugate type and injection site to 
overall labeled POA neurons are reported as beta coefficients and 95% 
confidence intervals in the regression results.
lower upper
Neither 0 5.4 1 -10.5 10.5
PEI only -6 4.9 0.21 -15.6 3.5
VGLUT-2 only 2.3 5.1 0.65 -7.6 12.3
Both 11.6 5.4 0.03 1 22.3
Tissue type 11.7 3.4 0.001 5 18.5
Time (m in) -0.2 0.1 0.07 -0.3 0







The regression model described above (Table 1) also estimated the 
incremental effect of individual conjugates on POA labeling efficacy, 
where deconjugated probe configurations exhibited decreased overall 
labeling efficiency (Fig. 7). When compared to baseline performance of 
the "naked" 5 nm probe, the average increase/decrease in POA 
neurons labeled were calculated by conjugate type, statistically 
controlling for other factors. While adding either VGLUT-2 or PEI 
individually may affect the efficacy of the probe, only the attachment 
and interaction of both conjugates significantly improved POA labeling 
over baseline (Table 1). I t  was also noted that, in tissues treated with 
control probes (especially unconjugated ones), somatic labeling was 
generally more sporadic and less specific to any particular region of 
the tissue. Because unconjugated, gold nanoprobes (like Probe D) are, 
by design, biocompatible and inert, they are unlikely to initiate the 
cell's immunological response and thus, be subject to degradation.
This property, when coupled with their miniscule size, makes "naked" 
nanoprobes more likely to pass through the synaptic machinery, than 
their larger, conjugated counterparts (Verma et al., 2008). To 
determine the effect of nanoprobe size, we enlarged the "naked" shells 
tenfold and compared the performance of these extra-large probes 
(Probe DX, diameter ~ 47 nm; peak reflectance = 530 nm; Nanopartz, 
Inc.) with their 5 nm counterparts. Fifty nanometers was chosen,
44
Figure 7. Labeling Efficacy By Probe Type. The median number of 
labeled POA neurons is significantly higher, when both VGLUT-2 and 
PEI conjugates are present, with Probe A reporting a bootstrapped 
population median estimate (iterations = 10,000) between 18-30 
labeled neurons per 50-nm slice.
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because it is at the uppermost lim its of synaptic vesicle diameters; 
most synaptic vesicles do not grow to be nearly this size (Harris and 
Sultan, 1995). Chi-square comparisons between Probe D and DX 
yielded a significant difference (Table 2) where Probe DX showed 
lesser POA labeling efficacy. Probe DX performed even less efficiently 
than all its 5-nm, deconjugated/unconjugated counterparts, registering 
a sim ilar POA labeling efficacy to non-DMH Probe A samples. Besides 
initial injection site and conjugate type, size may be another major 
factor affecting probe uptake (Chithrani et al., 2006). Differences 
between Probe D and DX's spatial distribution were not apparent in the 
anatomical position data.
Subsequent trials assessing the efficacy of the GABAergic probes 
(Probe Z; n = 23; Fig. 8a) yielded significantly lower POA labeling 
when compared to fully-conjugated glutamatergic probes (p < .001), 
despite statistically similar perfusion temperature, diffusion time, and 
initial injection volume. Spatial distribution patterns are similar to that 
of Probe A, where the densest labeling occurs in the anterior POA. I t  is 
dissimilar to Probe A, however, in that the lower overall labeling is 
reflected by lighter density shades (Fig. 8b). Potential explanations for 
the labeling disparity between the glutamatergic and GABAergic probes 
are explored in the Discussion section.
46
Table 2. Chi-square results by probe configuration or injection  
site. Overall, comparisons between probe configurations, based on 














Bold values are significant at the .05 level.
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Figure 8, a and b. Labeling Efficacy and Spatial Distribution of 
Probe Z. (a.) Probe Z labels POA neurons at a significantly lower 
efficacy rate than Probe A (p < .001).
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(b .) Spatial distribution of Probe Z in targ et tissue. Grid: The 
origin represents the DMH injection site. Higher axis numbers indicate 
a more dorsal direction, while lower axis letters indicate a more caudal 
direction. Oval denotes POA area. Each grid cell is approximately 100 
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To determine whether passive diffusion or facilitated axonal transport 
contributes primarily to somatic probe deposition, control tissues were 
treated with colchicine. Colchicine inhibits microtubule formation, and 
consequently, shuts down axoplasmic transport. POA labeling is 
significantly (p < .01) and substantially decreased upon colchicine 
administration (Fig. 9a), when compared to the non-colchicine 
treatment. Spatial distribution analysis also confirms that in colchicine- 
treated tissue, probes visualized outside the injection site tend to 
remain proximal to their synaptic entry points (Fig. 9b). From this we 
conclude, that nanoprobe deposition in the soma is substantially 
facilitated by the axonal transport machinery. The precise mechanism, 
by which these probes "hitch a ride" to the soma, remains unknown 
and may warrant further study.
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Figure 9, a and b. Effect of Colchicine on POA Labeling and 
Spatial Distribution, (a.) Simultaneous administration of 100 nM 
colchicine and Probe A significantly curtails POA labeling (p=.007), 
suggesting facilitated axonal transport of nanoprobes.
Effect of Colchicine on POA Labeling Efficacy
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(b.) Spatial distribution of visualized probes in tissue treated with 100 
nM colchicine. Grid: The origin represents the DMH injection site. 
Higher axis numbers indicate a more dorsal direction, while lower axis 
letters indicate a more caudal direction. Oval denotes POA area. Each 
grid cell is approximately 100 microns long. Key: Number of labeled 







4. D ISCUSSIO N
The mechanisms, by which the nervous system maintains or adjusts 
body temperature in response to thermal stressors, remain a 
fundamental area of study in physiology. Recent studies suggest that 
responses, such as hyperthermia, can be elicited by activation of 
neurons in the DMH and RPa, which receive direct input from 
thermally-responsive neurons in the POA. Therefore, in order to 
produce distinct changes in thermoregulatory control, these POA 
neurons may have direct axonal connections to the DMH or RPa. 
Phenotypical and connectivity assessments of neuronal populations 
within these areas could provide insight to their functional physiology.
Since VGLUT expression acts as a specific biomarker of a neuron's 
glutamatergic phenotype (Santos et al., 2009), it is a sufficient 
indicator of the glutamatergic machinery's presence within the 
terminal. Of the three known neuronal VGLUT isoforms, hypothalamic 
synapses predominantly express VGLUT-2 (Varoqui et al., 2002). 
Therefore, it is reasonable to conclude that probes with the VGLUT-2 
antibody are preferentially binding to and being endocytosed in 
glutamatergic axon terminals. By observing and quantifying neurons 
labeled with Probe A, we were able to simultaneously ascertain a likely
glutamatergic phenotype, while confirming connections between the 
DMH and the POA.
Although a median of approximately 20+ labeled neurons (out of a 
population of thousands within the POA) may seem small, this number 
only represents labeling from intact neurons within a single 400 pm 
section, during a time course of only a few hours. Furthermore, when 
considering the number of oblique, axonal fibers severed during the 
slicing process, labeling of 60 or more neurons (like the outlier in Fig. 
4) is still possible.
To understand the incremental contribution of the probe's constituent 
parts, we need to elaborate on the mechanisms by which they affect 
efficacy rates. Terminal uptake and endosomal escape can be classified 
in two ways: facilitated and passive. During vesicular uptake, probes 
with the VGLUT-2 antibodies (Probe A and B) were more likely to enter 
and remain with the vesicles, since they are more likely to bind to 
exposed VGLUT-2s and be co-transported into the lumen upon 
vesicular formation. Though still possible through passive diffusion, 
non-VGLUT-2 probes (C and D) are less likely to be actively taken into 
vesicles.
Once inside the vesicular lumen, the probe's fate is co-determined with 
that of the vesicle. Excluding degradation, three proposed, post-uptake 
vesicular mechanisms may affect probe efficacy. Vesicles may exist in 
a transient kiss-and-run cycle, a short-term recycling pool, or a long­
term reserve pool (Ceccarelii et al., 1973; Heuser and Reese, 1973;
Wu et al., 2007). Although the molecular processes underlying the 
kiss-and-run recycling mechanism are still unclear, this pathway is too 
transient for any appreciable probe vesicular entry; it may even return 
probes into the synaptic cleft. I t  is therefore unlikely to be a starting 
point for probes that reach the soma. Vesicles that follow the short­
term recycling pool or long-term reserve pool pathway exist long 
enough to be reasonable probe entry points. Probes that display PEI 
conjugates (Probe A and C) take advantage of the "proton sponge 
effect", which facilitates their escape into the cytosol. Non-PEI probes 
(Probe B and D) are less likely to exit intact vesicles, since the 
vesicular plasma membrane presents a significant barrier. Due to 
physical obstruction, non-PEI probes can presumably exit into the 
cytosol, in appreciable amounts, only when the vesicle itself and 
integral membrane proteins, are lysed and degraded by the cellular 
machinery.
As a consequence of the relative absence of lysosomes within the 
presynaptic terminal, integral vesicular membrane proteins are 
retrogradely transported to the soma, where they are destroyed by 
lysosomes (Li and Dahlstrom, 1997; Tsukita and Ishikawa, 1980). In 
this sense, we can explain the near similarities in Probe B and C's 
efficacy rates in the following way: while probes with the VGLUT-2- 
antibody are more likely to remain within the vesicles, and therefore 
be present in larger numbers post-formation, only a small percentage 
escape passively into the cytosol and reach the soma, presumably 
through vesicle degradation. For PEI-conjugated probes, the reverse is 
true: while relatively fewer of them passively remain in the vesicle 
post-formation, those that do are more likely to actively escape into 
the cytosol, through vesicle osmolysis, and transport to the soma. 
Furthermore, the absence of either the VGLUT-2 or VGAT antibody 
renders these particular probes to enter neurons nonspecificaily, with 
regards to phenotype. While it is clear that possessing either conjugate 
may be sufficient to reach the soma, efficacy rates are significantly 
much higher and more specific, when both are concurrently present, to 
take advantage of as many vesicular pathways as possible.
Although conjugate type plays a significant role, overall size may also 
influence probe efficacy. While adding the appropriate conjugates
facilitates probe specificity, it also adds to the probe complex's size. 
The larger the size, the more likely steric effects (such as blockage or 
entanglement) may influence efficacy. We are likely seeing this effect 
when comparing the relatively larger Probe C complex with that of 
Probe D (Table 2). Despite Probe D's lack of any facilitative 
conjugates, tissue injected with this "naked" probe shows a 
comparable efficacy rate to its deconjugated counterpart.
Concurrently, we also observe that merely increasing the probe shell 
size, as in the case of Probe DX, is sufficient to diminish efficacy rates. 
When coupled with its biocompatibility, the unconjugated, 5-nm 
probes take advantage of various mechanisms to enter neurons, which 
their conjugated counterparts cannot, such as occasionally passing 
interstitia ily through the plasma membrane (Verma et al., 2008). From 
this, we observe that the trade-off in specificity is mobility.
As for the GABAergic probes, it seems unusual that Probe Z labels POA 
neurons at a significantly lower efficacy rate, especially when the 
GABAergic phenotype comprises the majority of hypothalamic neurons 
(~60% ). Several mitigating factors, however, may explain the lower 
than expected rate.
From a chemical standpoint, VGAT's binding potential to its 
endogenous cargo (GABA), is different from VGLUT-2's interaction with 
its endogenous ligand (glutamate). I f  the principle of a "molecular 
velcro" does apply to the facilitated vesicular entry of these probes, 
then it is reasonable to assume that the differential binding kinetics 
between these two transporters may affect the binding interactions 
with their respective probes. This, in turn, alters the likelihood of 
vesicular uptake and therefore, somatic labeling. Furthermore, at 
physiological temperatures (~36°C), glutamate is endocytosed at 
faster rates and in larger vesicular compartments (approximately 4-5 
fold; Roskoski, 1978). These differences may be related to glutamate's 
general metabolic role in neuronal cells, as opposed to GABA's more 
specialized, neurotransmitter capacity.
5. CONCLUSIONS AND FUTURE DIRECTIONS
Several validation studies, to further assess the technique's viability, 
are currently under way. For example, direct histochemical techniques 
are being applied to verify and establish the accuracy of each probe's 
phenotypic-tagging capabilities. In another study, we are attempting 
to patch clamp from live, labeled neurons and then ascertain 
attenuations (or enhancements) from recorded electrical signals, if
any. Preliminary indications from patch clamp attempts, suggest that 
labeled neurons do remain viable and are still capable of displaying 
firing patterns.
The possibilities for future studies are numerous. As the body of 
nanobiotechnological knowledge grows, miniaturization technologies 
mature, and novel materials are introduced, future refinement of this 
technique is inevitable. This methodology has already demonstrated its 
wide applicability, by allowing conjugation of glutamatergic and 
GABAergic antibodies, and thereby targeting the two most abundant 
neurotransmitter systems in the central nervous system. Countless 
conjugate permutations could allow for specific visualization, 
customized characterization, connectivity assessment, and 
electrophysiological recording of hypothalamic cells and various other 
neuronal populations (e.g. cortical, hippocampal, interneuronal, etc.) 
within the brain and its periphery.
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